Sign in

CIK 0001798749

  • Emerging growth company

Jade Biosciences, Inc.

Sign in to watch
Ticker
JBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
831377888
Phone
+1 781-312-3013
Business address
221 CRESCENT ST., BUILDING 23, SUITE 105, WALTHAM, MA, 02453
Former names
Aerovate Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 84 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −200 13,894
2023-07-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −650 42,108
2023-07-05 NIVEN RALPH CHIEF SCIENTIFIC OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −750 50,732
2023-07-03 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise 10b5-1 +10,000 $2.14 $21K 10,000
2023-07-03 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Sale 10b5-1 −10,000 $18.00 $180K 0
2023-07-03 NOYES TIMOTHY P CHIEF EXECUTIVE OFFICER Option exercise · Stock Option (Right to Buy) 10b5-1 −10,000 393,381
2023-06-06 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +2,412 $1.74 $4K 3,703
2023-06-06 Dake Benjamin T SEE REMARKS Option exercise 10b5-1 +7,871 $2.14 $17K 11,574
2023-06-06 Dake Benjamin T SEE REMARKS Sale 10b5-1 −10,268 $16.28 $167K 1,306
2023-06-06 Dake Benjamin T SEE REMARKS Sale 10b5-1 −15 $16.98 $255 1,291
2023-06-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −905 6,339
2023-06-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −1,507 21,095
2023-06-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −1,018 22,405
2023-06-06 Dake Benjamin T SEE REMARKS Option exercise · Stock Option (Right to Buy) 10b5-1 −6,853 164,461
2023-06-06 Santel Donald J Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2023-06-06 Katabi Maha Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2023-06-06 GRAYZEL DAVID S. Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2023-06-06 Resnick Joshua Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2023-06-06 Iwicki Mark T Director Grant or award · Stock Option (Right to Buy) +12,500 12,500
2023-06-06 Dorval Allison Director Grant or award · Stock Option (Right to Buy) +12,500 12,500

Page 15 of 16 · 315 trades